tiprankstipranks
Alibaba Health Information Technology Ltd. (HK:0241)
:0241
Hong Kong Market
0241
Alibaba Health Information Technology
RESEARCH TOOLSreports
Want to see HK:0241 full AI Analyst Report?

Alibaba Health Information Technology (0241) Stock Forecast & Price Target

24 Followers
See the Price Targets and Ratings of:

0241 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Alibaba
Health Information Technology
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0241 Stock 12 Month Forecast

There Are No Analyst Ratings for HK:0241 In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

0241 Financial Forecast

0241 Earnings Forecast

Next quarter’s earnings estimate for 0241 is HK$0.09 with a range of HK$0.09 to HK$0.09. The previous quarter’s EPS was HK$0.07. 0241 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0241 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 0241 is HK$0.09 with a range of HK$0.09 to HK$0.09. The previous quarter’s EPS was HK$0.07. 0241 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0241 has Performed in-line its overall industry.

0241 Sales Forecast

Next quarter’s sales forecast for 0241 is HK$21.31B with a range of HK$21.03B to HK$21.59B. The previous quarter’s sales results were HK$19.53B. 0241 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0241 has Performed in-line its overall industry.
Next quarter’s sales forecast for 0241 is HK$21.31B with a range of HK$21.03B to HK$21.59B. The previous quarter’s sales results were HK$19.53B. 0241 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0241 has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on HK:0241
Cui Cui
Jefferies
Jefferies
HK$5.3
Buy
65.62%
Upside
Reiterated
05/19/26
Jefferies Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)
Goldman Sachs Analyst forecast on HK:0241
Lincoln Kong
Goldman Sachs
Goldman Sachs
HK$4.8→HK$4.2
Hold
31.25%
Upside
Reiterated
05/19/26
Goldman Sachs Remains a Hold on Alibaba Health Information Technology (ALBHF)
Huatai Securities Analyst forecast on HK:0241
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
HK$5.66→HK$4.92
Buy
53.75%
Upside
Reiterated
05/18/26
Huatai Securities Remains a Buy on Alibaba Health Information Technology (ALBHF)
CICC Analyst forecast on HK:0241
Unknown Analyst
CICC
Not Ranked
CICC
HK$6.5
Buy
103.12%
Upside
Reiterated
05/16/26
CICC Remains a Buy on Alibaba Health Information Technology (ALBHF)
Morgan Stanley Analyst forecast on HK:0241
Alexis Yan
Morgan Stanley
Morgan Stanley
HK$4.2
Sell
31.25%
Upside
Reiterated
05/15/26
Morgan Stanley’s Alexis Yan Reiterates Sell on Alibaba Health Amid Weak Earnings Momentum and High Upfront Investment Costs
Bank of America Securities Analyst forecast on HK:0241
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
HK$6
Buy
87.50%
Upside
Reiterated
04/14/26
Bank of America Securities Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)
UOB Kay Hian Analyst forecast on HK:0241
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
HK$6
Buy
87.50%
Upside
Reiterated
04/14/26
Alibaba Health Information Technology (ALBHF) Gets a Buy from UOB Kay Hian
GF Securities Analyst forecast on HK:0241
Unknown Analyst
GF Securities
Not Ranked
GF Securities
HK$7.39→HK$6.29
Buy
96.56%
Upside
Reiterated
04/09/26
GF Securities Sticks to Their Buy Rating for Alibaba Health Information Technology (ALBHF)
CLSA Analyst forecast on HK:0241
Unknown Analyst
CLSA
Not Ranked
CLSA
HK$5.3
Buy
65.62%
Upside
Reiterated
04/08/26
CLSA Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)
UBS Analyst forecast on HK:0241
Unknown Analyst
UBS
Not Ranked
UBS
HK$4.1
Sell
28.12%
Upside
Reiterated
04/07/26
UBS Remains a Sell on Alibaba Health Information Technology (ALBHF)
HSBC Analyst forecast on HK:0241
Unknown Analyst
HSBC
Not Ranked
HSBC
HK$6.5
Hold
103.12%
Upside
Reiterated
02/09/26
Alibaba Health Information Technology (ALBHF) Gets a Hold from HSBC
Citi Analyst forecast on HK:0241
Unknown Analyst
Citi
Not Ranked
Citi
HK$9
Buy
181.25%
Upside
Reiterated
02/05/26
Citi Sticks to Its Buy Rating for Alibaba Health Information Technology (ALBHF)
Citic Securities Analyst forecast on HK:0241
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
HK$12.1
Buy
278.12%
Upside
Reiterated
01/15/26
Guotai Haitong Analyst forecast on HK:0241
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
HK$5.69
Buy
77.81%
Upside
Reiterated
12/03/25
Alibaba Health Information Technology (ALBHF) Gets a Buy from Guotai Haitong
J.P. Morgan Analyst forecast on HK:0241
Alex Yao
J.P. Morgan
J.P. Morgan
HK$5→HK$6.5
Hold
103.12%
Upside
Reiterated
09/17/25
Alibaba Health Information Technology (ALBHF) Receives a Hold from J.P. Morgan
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on HK:0241
Cui Cui
Jefferies
Jefferies
HK$5.3
Buy
65.62%
Upside
Reiterated
05/19/26
Jefferies Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)
Goldman Sachs Analyst forecast on HK:0241
Lincoln Kong
Goldman Sachs
Goldman Sachs
HK$4.8→HK$4.2
Hold
31.25%
Upside
Reiterated
05/19/26
Goldman Sachs Remains a Hold on Alibaba Health Information Technology (ALBHF)
Huatai Securities Analyst forecast on HK:0241
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
HK$5.66→HK$4.92
Buy
53.75%
Upside
Reiterated
05/18/26
Huatai Securities Remains a Buy on Alibaba Health Information Technology (ALBHF)
CICC Analyst forecast on HK:0241
Unknown Analyst
CICC
Not Ranked
CICC
HK$6.5
Buy
103.12%
Upside
Reiterated
05/16/26
CICC Remains a Buy on Alibaba Health Information Technology (ALBHF)
Morgan Stanley Analyst forecast on HK:0241
Alexis Yan
Morgan Stanley
Morgan Stanley
HK$4.2
Sell
31.25%
Upside
Reiterated
05/15/26
Morgan Stanley’s Alexis Yan Reiterates Sell on Alibaba Health Amid Weak Earnings Momentum and High Upfront Investment Costs
Bank of America Securities Analyst forecast on HK:0241
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
HK$6
Buy
87.50%
Upside
Reiterated
04/14/26
Bank of America Securities Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)
UOB Kay Hian Analyst forecast on HK:0241
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
HK$6
Buy
87.50%
Upside
Reiterated
04/14/26
Alibaba Health Information Technology (ALBHF) Gets a Buy from UOB Kay Hian
GF Securities Analyst forecast on HK:0241
Unknown Analyst
GF Securities
Not Ranked
GF Securities
HK$7.39→HK$6.29
Buy
96.56%
Upside
Reiterated
04/09/26
GF Securities Sticks to Their Buy Rating for Alibaba Health Information Technology (ALBHF)
CLSA Analyst forecast on HK:0241
Unknown Analyst
CLSA
Not Ranked
CLSA
HK$5.3
Buy
65.62%
Upside
Reiterated
04/08/26
CLSA Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)
UBS Analyst forecast on HK:0241
Unknown Analyst
UBS
Not Ranked
UBS
HK$4.1
Sell
28.12%
Upside
Reiterated
04/07/26
UBS Remains a Sell on Alibaba Health Information Technology (ALBHF)
HSBC Analyst forecast on HK:0241
Unknown Analyst
HSBC
Not Ranked
HSBC
HK$6.5
Hold
103.12%
Upside
Reiterated
02/09/26
Alibaba Health Information Technology (ALBHF) Gets a Hold from HSBC
Citi Analyst forecast on HK:0241
Unknown Analyst
Citi
Not Ranked
Citi
HK$9
Buy
181.25%
Upside
Reiterated
02/05/26
Citi Sticks to Its Buy Rating for Alibaba Health Information Technology (ALBHF)
Citic Securities Analyst forecast on HK:0241
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
HK$12.1
Buy
278.12%
Upside
Reiterated
01/15/26
Guotai Haitong Analyst forecast on HK:0241
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
HK$5.69
Buy
77.81%
Upside
Reiterated
12/03/25
Alibaba Health Information Technology (ALBHF) Gets a Buy from Guotai Haitong
J.P. Morgan Analyst forecast on HK:0241
Alex Yao
J.P. Morgan
J.P. Morgan
HK$5→HK$6.5
Hold
103.12%
Upside
Reiterated
09/17/25
Alibaba Health Information Technology (ALBHF) Receives a Hold from J.P. Morgan
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PTGXProtagonist Therapeutics
AXGNAxoGen
ATECAlphatec Holdings
CABACabaletta Bio
ONCBeOne Medicines
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Alibaba Health Information Technology

3 Months
Alexis YanMorgan Stanley
Success Rate
3/3 ratings generated profit
100%
Average Return
+9.37%
Copying Alexis Yan's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +9.37% per trade.
1 Year
Alexis YanMorgan Stanley
Success Rate
3/3 ratings generated profit
100%
Average Return
+36.20%
Copying Alexis Yan's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +36.20% per trade.
2 Years
Alexis YanMorgan Stanley
Success Rate
3/3 ratings generated profit
100%
Average Return
+36.20%
Copying Alexis Yan's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +36.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0241 Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
1
1
1
0
0
Buy
7
7
2
0
0
Hold
2
2
1
0
0
Sell
2
2
1
0
0
Strong Sell
0
0
0
0
0
total
12
12
5
0
0
In the current month, 0241 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0241 average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

0241 Stock Forecast FAQ

What is HK:0241’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:0241’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:0241, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Alibaba Health Information Technology Ltd. a Buy, Sell or Hold?
      Currently, no data Available
      What is Alibaba Health Information Technology Ltd.’s share price target?
      Currently, no data Available
      What do analysts say about Alibaba Health Information Technology Ltd.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Alibaba Health Information Technology Ltd.?
      To buy shares of HK:0241, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.